Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Heim

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Blood|May 5, 2009
Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sexGabriela M Baerlocher, Alicia Rovó, Astrid Müller, et al.
The Lancet. Haematology|June 7, 2017
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trialJürgen Finke, Claudia Schmoor, Wolfgang Andreas Bethge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantationMartin Stern, Jakob Passweg, Jean-Marie Tiercy, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|January 31, 2012
A pilot case-control study of behavioral aspects and risk factors in Swiss climbersRebecca M Hasler, Priska Bach, Monika Brodmann, et al.
Journal for Immunotherapy of Cancer|December 1, 2022
Dasatinib for treatment of CAR T-cell therapy-related complicationsKatharina Baur, Dominik Heim, Astrid Beerlage, et al.
Annals of Hematology|December 14, 2018
Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantationMonica Bianchi, Dominik Heim, Claudia Lengerke, et al.
Transfusion|January 23, 2008
Patient and product factors affecting platelet transfusion resultsDominik Heim, Jakob Passweg, Michael Gregor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2008
Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literatureNina Khanna, Andreas F Widmer, Michael Decker, et al.
Swiss Medical Weekly|May 15, 2024
Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugsDominik Heim, Helen Baldomero, Michael Medinger, et al.
In Vivo (Athens, Greece)|November 4, 2020
New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell TransplantationVera Dalla Via, JÖrg P Halter, Sabine Gerull, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Blood|May 5, 2009
Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sexGabriela M Baerlocher, Alicia Rovó, Astrid Müller, et al.
The Lancet. Haematology|June 7, 2017
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trialJürgen Finke, Claudia Schmoor, Wolfgang Andreas Bethge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantationMartin Stern, Jakob Passweg, Jean-Marie Tiercy, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|January 31, 2012
A pilot case-control study of behavioral aspects and risk factors in Swiss climbersRebecca M Hasler, Priska Bach, Monika Brodmann, et al.
Journal for Immunotherapy of Cancer|December 1, 2022
Dasatinib for treatment of CAR T-cell therapy-related complicationsKatharina Baur, Dominik Heim, Astrid Beerlage, et al.
Annals of Hematology|December 14, 2018
Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantationMonica Bianchi, Dominik Heim, Claudia Lengerke, et al.
Transfusion|January 23, 2008
Patient and product factors affecting platelet transfusion resultsDominik Heim, Jakob Passweg, Michael Gregor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2008
Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literatureNina Khanna, Andreas F Widmer, Michael Decker, et al.
Swiss Medical Weekly|May 15, 2024
Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugsDominik Heim, Helen Baldomero, Michael Medinger, et al.
In Vivo (Athens, Greece)|November 4, 2020
New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell TransplantationVera Dalla Via, JÖrg P Halter, Sabine Gerull, et al.
Pageof 12